Plasma and Lp (a)-associated Lp-PLA2 activity was evaluated in mild-moderate CKD patients, CAPD and HD patients; all patient groups showed significantly increased Lp(a) levels and Lp-PLA2 activity [30]. This evidence concerns the gene PLA2G7 and chronic kidney disease.